Related references
Note: Only part of the references are listed.Genetic Diversity, Complicated Recombination, and Deteriorating Drug Resistance Among HIV-1-Infected Individuals in Wuhan, China
Yan Zhang et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)
Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy
Lan Wei et al.
RETROVIROLOGY (2021)
The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China
Mengze Gan et al.
EMERGING MICROBES & INFECTIONS (2021)
Optimizing Treatment for Adults with HIV/AIDS in China: Successes over Two Decades and Remaining Challenges
Wei Cao et al.
CURRENT HIV/AIDS REPORTS (2020)
Pretreatment HIV drug resistance in adults initiating antiretroviral therapy in China, 2017
Rui-Hua Kang et al.
INFECTIOUS DISEASES OF POVERTY (2020)
HIV-1 Genetic Diversity and High Prevalence of Pretreatment Drug Resistance in Tianjin, China
Rui Zeng et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2020)
Retrospective analysis of HIV-1 drug resistance mutations in Suzhou, China from 2009 to 2014
Yanhui Song et al.
VIRUS GENES (2020)
Characteristics of HIV-1 molecular transmission networks and drug resistance among men who have sex with men in Tianjin, China (2014-2018)
Minna Zheng et al.
VIROLOGY JOURNAL (2020)
Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure
Amir Shroufi et al.
AIDS (2019)
Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China
Zhenyan Wang et al.
BMC INFECTIOUS DISEASES (2019)
Surveillance of HIV-1 drug resistance in Xinjiang: high prevalence of K103N in treatment-naive individuals
Zhanjun Shu et al.
ARCHIVES OF VIROLOGY (2018)
Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Zhejiang, China, 2014-2017
Yufan Xu et al.
ARCHIVES OF VIROLOGY (2018)
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial
James G. Hakim et al.
LANCET INFECTIOUS DISEASES (2018)
The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action
Silvia Bertagnolio et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub-Saharan Africa
Andrew N. Phillips et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China
Fengdi Zhang et al.
PLOS ONE (2017)
Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission network
Joel O. Wertheim et al.
VIRUS EVOLUTION (2017)
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial
Rami Kantor et al.
CLINICAL INFECTIOUS DISEASES (2015)
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing
George L. Melikian et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine
Roger Paredes et al.
JOURNAL OF VIROLOGY (2009)
Current progress of China's free ART program
FJ Zhang et al.
CELL RESEARCH (2005)
An automated genotyping system for analysis of HIV-1 and other microbial sequences
T de Oliveira et al.
BIOINFORMATICS (2005)
Share Paper
